- Home
- LAZR vs TIL Comparison
LAZR vs TIL Comparison
Compare LAZR & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZR
- TIL
- Stock Information
- Founded
- LAZR 2012
- TIL 2018
- Country
- LAZR United States
- TIL United States
- Employees
- LAZR N/A
- TIL N/A
- Industry
- LAZR Auto Parts:O.E.M.
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- LAZR Consumer Discretionary
- TIL Health Care
- Exchange
- LAZR Nasdaq
- TIL Nasdaq
- Market Cap
- LAZR 176.7M
- TIL 177.1M
- IPO Year
- LAZR N/A
- TIL 2021
- Fundamental
- Price
- LAZR $2.16
- TIL $20.41
- Analyst Decision
- LAZR Sell
- TIL Strong Buy
- Analyst Count
- LAZR 3
- TIL 5
- Target Price
- LAZR $8.00
- TIL $100.67
- AVG Volume (30 Days)
- LAZR 6.4M
- TIL 166.4K
- Earning Date
- LAZR 11-10-2025
- TIL 11-12-2025
- Dividend Yield
- LAZR N/A
- TIL N/A
- EPS Growth
- LAZR N/A
- TIL N/A
- EPS
- LAZR N/A
- TIL N/A
- Revenue
- LAZR $72,496,000.00
- TIL N/A
- Revenue This Year
- LAZR N/A
- TIL N/A
- Revenue Next Year
- LAZR $12.58
- TIL N/A
- P/E Ratio
- LAZR N/A
- TIL N/A
- Revenue Growth
- LAZR N/A
- TIL N/A
- 52 Week Low
- LAZR $1.58
- TIL $10.80
- 52 Week High
- LAZR $18.60
- TIL $45.07
- Technical
- Relative Strength Index (RSI)
- LAZR 50.97
- TIL 47.97
- Support Level
- LAZR $2.02
- TIL $17.37
- Resistance Level
- LAZR $2.47
- TIL $21.45
- Average True Range (ATR)
- LAZR 0.23
- TIL 1.48
- MACD
- LAZR 0.02
- TIL 0.44
- Stochastic Oscillator
- LAZR 45.74
- TIL 81.28
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.